Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mingdong Li
Observed names:
Li, M.,
M. Li,
Musu Li
Institution:
Jiangxi University of Traditional Chinese Medicine
Observed institutions:
Jiangxi University of Traditional Chinese Medicine,
Chinese Academy of Medical Sciences & Peking Union Medical College,
Hainan General Hospital,
Cancer Hospital of Chinese Academy of Medical Sciences,
Hainan Medical University,
Nanjing Medical University
show all 6
ORCID:
0000-0002-0262-1076
Observed ORCID:
0000-0002-0262-1076
OpenAlex ID:
A5005884908
Discovery of 4-((3,4-dichlorophenyl)amino)-2-methylquinolin-6-ol derivatives as EGFR and HDAC dual inhibitors
2023
·
Yuqing Qian
, Siyu Zhou
, et al.
·
European Journal of Pharmacology
·
16
Multi-omics Data Integration Analysis Identified Therapeutic Targets and Potential Reuse Drugs for Osteoporosis
2024
·
Mingdong Li
, Xing Gao
, et al.
·
Current Medicinal Chemistry
·
6
Histone Deacetylase Inhibitor Entinostat Exerts Anti-NSCLC Effects Through the EGFR Signaling Pathway and MDM2-p53 Axis
2026
·
Sinian He
, Aoxuan Zhang
, et al.
·
Current Pharmaceutical Biotechnology
·
3
Integration of Multi-omics Data Based on Deep Learning for Subtyping of Low-Grade Glioma
2025
·
Huilin Li
, Musu Li
, et al.
·
Journal of Molecular Neuroscience
·
3
Protopine, a promising novel histone deacetylase 6 inhibitor reduces tauopathy in in vitro and in vivo
2015
·
Durairajan, Siva Sundara Kumar
, Li, M.
, et al.
·
HKBU Institutional Repository (Hong Kong Baptist University)
·
2
P3.06F.04 Multi-Omics Analysis of SMARCA4-Deficient Tumors
2024
·
Y. Dong
, M. Li
, et al.
·
Journal of Thoracic Oncology
·
1
Propionate metabolism‑related genes demonstrate the potential to serve as prognostic and immunotherapeutic markers in osteosarcoma
2025
·
Wei Liu
, Ze Xu
, et al.
·
Oncology Letters
Show more works
View as search
Works count:
8
Citation count:
31
H-index:
3
I10-index:
1
Year
Topic
Type